Creative Planning’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-773
| Closed | -$10K | – | 2897 |
|
|
2023
Q4 | $10K | Hold |
773
| – | – | ﹤0.01% | 2697 |
|
|
2023
Q3 | $15.5K | Hold |
773
| – | – | ﹤0.01% | 2578 |
|
|
2023
Q2 | $20.8K | Hold |
773
| – | – | ﹤0.01% | 2476 |
|
|
2023
Q1 | $45.1K | Hold |
773
| – | – | ﹤0.01% | 2335 |
|
|
2022
Q4 | $39.4K | Hold |
773
| – | – | ﹤0.01% | 2238 |
|
|
2022
Q3 | $63K | Hold |
773
| – | – | ﹤0.01% | 2076 |
|
|
2022
Q2 | $52K | Sell |
773
-100
| -11% | -$6.73K | ﹤0.01% | 2029 |
|
|
2022
Q1 | $97K | Hold |
873
| – | – | ﹤0.01% | 1985 |
|
|
2021
Q4 | $84K | Sell |
873
-200
| -19% | -$19.2K | ﹤0.01% | 1966 |
|
|
2021
Q3 | $94K | Hold |
1,073
| – | – | ﹤0.01% | 1940 |
|
|
2021
Q2 | $166K | Sell |
1,073
-1,246
| -54% | -$193K | ﹤0.01% | 1813 |
|
|
2021
Q1 | $366K | Sell |
2,319
-1,222
| -35% | -$193K | ﹤0.01% | 1628 |
|
|
2020
Q4 | $822K | Buy |
3,541
+2,363
| +201% | +$549K | ﹤0.01% | 1033 |
|
|
2020
Q3 | $258K | Buy |
+1,178
| New | +$258K | ﹤0.01% | 1500 |
|
|
2019
Q4 | – | Sell |
-13,597
| Closed | -$1.96M | – | 1918 |
|
|
2019
Q3 | $1.96M | Buy |
+13,597
| New | +$1.96M | 0.01% | 497 |
|
|
2017
Q3 | – | Sell |
-333
| Closed | -$45K | – | 2799 |
|
|
2017
Q2 | $45K | Hold |
333
| – | – | ﹤0.01% | 2581 |
|
|
2017
Q1 | $64K | Sell |
333
-47
| -12% | -$9.03K | ﹤0.01% | 2275 |
|
|
2016
Q4 | $54K | Buy |
380
+47
| +14% | +$6.68K | ﹤0.01% | 2317 |
|
|
2016
Q3 | $49K | Hold |
333
| – | – | ﹤0.01% | 2359 |
|
|
2016
Q2 | $34K | Hold |
333
| – | – | ﹤0.01% | 2390 |
|
|
2016
Q1 | $45K | Sell |
333
-2
| -0.6% | -$270 | ﹤0.01% | 2163 |
|
|
2015
Q4 | $67K | Hold |
335
| – | – | ﹤0.01% | 1864 |
|
|
2015
Q3 | $53K | Buy |
+335
| New | +$53K | ﹤0.01% | 1996 |
|
|
2015
Q2 | – | Sell |
-2
| Closed | -$1K | – | 2024 |
|
|
2015
Q1 | $1K | Sell |
2
-33
| -94% | -$16.5K | ﹤0.01% | 3907 |
|
|
2014
Q4 | $20K | Buy |
+35
| New | +$20K | ﹤0.01% | 2628 |
|